Application 205366
- Type
- ANDA
- Sponsor
- PAR STERILE PRODUCTS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 200MCG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A205366-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A205366-001 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | 2015-12-07 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | ffc34bc6-5de5-addb-e053-6294a90a25be | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 49136b34-1bc1-ec4e-e063-6394a90ac9dd | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | f2bed4e7-86e9-430e-80d9-7bd7cfcf9bf5 | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | levothyroxine sodium LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 8f7dc71e-4a48-4ba5-945b-f340ff51636e | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | levothyroxine sodium LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 36af0286-e447-4098-b3f2-772debd58667 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | Levothyroxine sodium LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | e8142948-2bde-4f4b-931e-da43e91f2d59 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | Levothyroxine sodium LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | d29bc0fd-5587-4a70-a505-f5aee1f115a6 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | Levothyroxine sodium LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | d5b11dac-1acd-4aa2-b837-e3b90d4f6922 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | Levothyroxine sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f6c92836-95e1-1402-e053-6394a90a2f5e | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | e2291336-1188-48f4-af52-d12ac892f80f | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 98d7ce2b-a248-4ed0-a2ec-d28ba623531e | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | 59a99739-2da5-46a7-8811-1169123bed9b | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | levothyroxine sodium LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | 579b1935-77f5-4381-9cb0-e0130e4834e8 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | levothyroxine sodium LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | 4e6dce46-cbf5-4353-9d0c-36b6f857197a | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | levothyroxine sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Lannett Company, Inc | a8db0f7d-8863-9309-e053-2995a90a284a | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 3d737f79-7fc9-4221-e063-6394a90ac9aa | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | c968836a-f94c-4d13-e053-2995a90a8df5 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db10e666-6204-56cc-e053-2995a90a9e08 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db5dd9d2-4f96-25d0-e053-2995a90af9dc | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | levothyroxine sodium LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | c9f4923e-5625-1d4f-e053-2a95a90aabc9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | levothyroxine sodium LEVOTHYROXINE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42023-161 | Levothyroxine Sodium | Levothyroxine Sodium Anhydrous | Par Pharmaceutical Companies, Inc. | ANDA | Current |